Increased risk of serotonin syndrome and potentiated sympathomimetic effects.
Should not be used concurrently with MAOIs or within 14 days of stopping MAOIs.
Source: G&G 14e
TCA · Antidepressant
Also known as Doxepin hydrochloride
Doxepin, a tricyclic antidepressant, functions by blocking the re-uptake of both serotonin and noradrenaline in the brain, though to varying degrees. This action increases the concentration of these neurotransmitters in the synaptic cleft, enhancing mood. Doxepin also possesses significant sedative properties, making it particularly useful for agitated and anxious patients.
Increased risk of serotonin syndrome and potentiated sympathomimetic effects.
Should not be used concurrently with MAOIs or within 14 days of stopping MAOIs.
Source: G&G 14e
Potentiation of adrenaline's effects.
Vasoconstrictor (adrenaline) containing LA should be avoided in patients receiving tricyclic antidepressants.
Source: KDT 7e · p365
Increased risk of cardiac conduction defects.
Source: KDT 7e · p816-835
Increased cardiotoxicity (e.g., QT prolongation).
Source: Harrison 22e · p1740
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
May increase plasma exposures of TCAs.
The possibility of drug interactions should be kept in mind until the safety of the combination is firmly established.
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e, Harrison 22e, Katzung, BNF·Verified: 2026-05-10 · House clinical team